About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Internuclear Ophthalmoplegia and Multiple Sclerosis: a Multicenter Retrospective Study

NCT07560995·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Kévin BIGAUT
CONTACT
+33 3 88 12 60 96 kevin.bigaut@chru-strasbourg.fr
Sebille COLIN
CONTACT
+33 3 88 11 52 17 sebille.colin@chru-strasbourg.fr

Lead

University Hospital, Strasbourg, France

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with internuclear ophthalmoplegia listed as a primary or associated diagnosis
Patients hospitalized in a neurology department

You may not be if

\- Patients under 18 years of age

The record

StatusNot yet recruiting

PhaseNo phase

Taking part200

StartedMay 2026

UpdatedMay 8, 2026

Conditions

Multiple Sclerosis Internuclear Ophthalmoplegia

Where1

Les Hôpitaux Universitaires
Strasbourg, France